NCT05973838 Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
| NCT ID | NCT05973838 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Maryland, College Park |
| Condition | Polysubstance Addiction |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2023-06-15 |
| Primary Completion | 2027-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2023-06-15 with a primary completion date of 2027-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among patients with OUD and polysubstance use in underserved areas. The intervention is based on behavioral activation (BA) and is specifically designed to be implemented by a trained peer recovery specialist. In this hybrid, Type-1 effectiveness-implementation randomized controlled trial (RCT), the investigators will evaluate the effectiveness and implementation of Peer Activate vs. treatment as usual (TAU) over twelve months.
Eligibility Criteria
Inclusion Criteria: Patient participants in the RCT must be 18 or older; receive OUD treatment as part of the telemedicine program; and exhibit polysubstance use within the past three-months (i.e., use of one or more non-prescribed substances (excluding opioids and/or tobacco) by urine toxicology or self-report. Exclusion Criteria: * Demonstrating active, unstable or untreated psychiatric symptoms, including mania and/or psychosis that would interfere with study participation * Inability to understand the study and provide informed consent in English
Contact & Investigator
Jessica F Magidson, PhD
PRINCIPAL INVESTIGATOR
University of Maryland, College Park
Frequently Asked Questions
Who can join the NCT05973838 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Polysubstance Addiction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05973838 currently recruiting?
Yes, NCT05973838 is actively recruiting participants. Contact the research team at manvari@umd.edu for enrollment information.
Where is the NCT05973838 trial being conducted?
This trial is being conducted at Washington D.C., United States, Baltimore, United States, College Park, United States, Denton, United States.
Who is sponsoring the NCT05973838 clinical trial?
NCT05973838 is sponsored by University of Maryland, College Park. The principal investigator is Jessica F Magidson, PhD at University of Maryland, College Park. The trial plans to enroll 160 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.